IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Lonza Acquires Cell Discovery Technology Firm

10:26 AM MDT | June 2, 2008 | Deepti Ramesh

Lonza says it has acquired Amaxa (Cologne, Germany), a technology supplier to the cell discovery market, for an undisclosed amount. The transaction is subject to anti-trust regulatory approval, which is expected to take place early in the third quarter, Lonza says. Amax provides high-end nucleic acid transfection systems and consumables to academic institutions and pharmaceutical and biotechnology businesses, Lonza says. Amaxa also has proprietary technologies in the niche transfection systems market. “Amaxa is an excellent fit with the Lonza Bioscience...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa